Borregaard ASA

Borregaard ASA develops, produces, and markets specialized biochemicals and biomaterials in Norway, the rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. BioSolutions develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as for flavor and fragrance companies and the food and beverage industry. BioMaterials develops, produces, and sells specialty cellulose used as a raw material in cellulose ethers, cellulose acetate, and other specialty products, along with cellulose fibrils for industrial applications. Fine Chemicals supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.

0QB7.LSE▼

Borregaard reports EBITDA of NOK 515 million in second quarter

Borregaard ASA reported EBITDA of NOK 515 million in the second quarter of 2026, slightly down from NOK 522 million a year earlier, as higher sales volume in BioSolutions was offset by increased energy costs, negative currency effects, and a less favourable product mix. Operating revenues rose to NOK 2,114 million from NOK 2,045 million, with improved results in BioMaterials and Fine Chemicals but a decline in BioSolutions. The company recorded a NOK 337 million impairment on its investment in Alginor ASA and NOK 30 million in other expenses for ground stabilisation at its Sarpsborg site, leading to a loss before tax of NOK 45 million compared with a profit of NOK 326 million in the prior-year period. Excluding those items, earnings per share were NOK 2.35. Borregaard is implementing a cost improvement programme targeting annual savings of NOK 150 million, with full effect expected from 2028.

0QB7.LSE ▼

GlobeNewswire·65dRead more →